Literature DB >> 8051364

[The M. Kapandji hysteropexy: a laparoscopic technic and preliminary results].

E Cornier1, P Madelenat.   

Abstract

OBJECTIVE. To develop a laparoscopic-assisted technique for the treatment of genital prolapsus. MODALITY. With the Kapandji's technique the vagina and the uterine isthmus is suspended transversally with a subperitoneal prosthesis. This technique has been favourably assessed in comparison with posterior suspension to the lumbo-sacral junction and is easily performed laparoscopically. Details of the technique will be given. CONCLUSION. This technique was simpler and less dangerous than colposuspension to the lumbo-sacral disc and gave functional results which were as good or better. This method also has the advantage of being performed via laparoscopy. Since the immediate post-operative convalescence is shorter and complete recovery can be achieved more rapidly, this is the method of choice for the treatment of genital prolapsus in young women.

Entities:  

Mesh:

Year:  1994        PMID: 8051364

Source DB:  PubMed          Journal:  J Gynecol Obstet Biol Reprod (Paris)        ISSN: 0150-9918


  4 in total

1.  Robotically assisted laparoscopic repair of anterior vaginal wall and uterine prolapse by lateral suspension with mesh: initial experience and video.

Authors:  Patrick Dällenbach; Nikolaus Veit
Journal:  Int Urogynecol J       Date:  2014-04-17       Impact factor: 2.894

Review 2.  To mesh or not to mesh: a review of pelvic organ reconstructive surgery.

Authors:  Patrick Dällenbach
Journal:  Int J Womens Health       Date:  2015-04-01

3.  Laparoscopic Lateral Suspension (LLS) for the Treatment of Apical Prolapse: A New Gold Standard?

Authors:  Patrick Dällenbach
Journal:  Front Surg       Date:  2022-05-12

4.  Laparoscopic lateral suspension for anterior and apical prolapse: a prospective cohort with standardized technique.

Authors:  Kyriaki Chatziioannidou; Nikolaus Veit-Rubin; Patrick Dällenbach
Journal:  Int Urogynecol J       Date:  2021-04-09       Impact factor: 2.894

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.